Evidence map›Paper›PMID 26293298›Full record

ArticleDevelopment (Cambridge, England)2015

A direct fate exclusion mechanism by Sonic hedgehog-regulated transcriptional repressors.

Yuichi Nishi, Xiaoxiao Zhang, Jieun Jeong, Kevin A Peterson, Anastasia Vedenko, Martha L Bulyk, Winston A Hide, Andrew P McMahon

Open access · bronzeAbstract read
In one paragraph

Article in Development (Cambridge, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 60 citations in OpenAlex.

  1. The Therapeutic Potential of Purmorphamine Across Disease Models.Journal of cellular and molecular medicine · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Yuichi NishiDepartment of Stem Cell Biology and Regenerative Medicine, Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research, University of Southern California Keck School of Medicine, Los Angeles, CA 90089, USA.
Xiaoxiao ZhangDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA.
Jieun JeongDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA Department of Biostatistics, Harvard School of Public Health, Boston, MA 02115, USA.
Kevin A PetersonDepartment of Stem Cell Biology and Regenerative Medicine, Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research, University of Southern California Keck School of Medicine, Los Angeles, CA 90089, USA.
Anastasia VedenkoDivision of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Martha L BulykDivision of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Winston A HideDepartment of Biostatistics, Harvard School of Public Health, Boston, MA 02115, USA Sheffield Institute for Translational Neuroscience, Department of Neuroscience, University of Sheffield, 385A Glossop Road, Sheffield S10 2HQ, UK.
Andrew P McMahonDepartment of Stem Cell Biology and Regenerative Medicine, Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research, University of Southern California Keck School of Medicine, Los Angeles, CA 90089, USA amcmahon@med.usc.edu.
Harvard University · USUniversity of Southern California · USBrigham and Women's Hospital · US

Funding

Regulation of polarity by Sonic hedgehog morphogen signalingR01NS033642 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MCMAHON, ANDREW P. · 1995 to 2016
$5.7M
Regulation of CNS and Limb Polarity by Sonic HedgehogR37NS033642 · NINDS · HARVARD UNIVERSITY · PI MCMAHON, ANDREW P. · 2005 to 2011
$5.6M
Universal, Compact Combinatorial Microarrays for DNA Binding Site DiscoveryR01HG003985 · NHGRI · BRIGHAM AND WOMEN'S HOSPITAL · PI BULYK, MARTHA L · 2006 to 2017
$4.9M
Harvard Stem Cell Institute Training Program for Pre- and Post-Doctoral FellowsT32HL087735 · NHLBI · HARVARD UNIVERSITY · PI SCADDEN, DAVID T · 2008 to 2012
$1.7M
NHGRI NIH HHS R01 HG003985NHLBI NIH HHS T32 HL087735NINDS NIH HHS R01 NS033642NINDS NIH HHS R37 NS033642NINDS NIH HHS R37NS033642
6 · The paper itself

Abstract

Sonic hedgehog (Shh) signaling patterns the vertebrate spinal cord by activating a group of transcriptional repressors in distinct neural progenitors of somatic motor neuron and interneuron subtypes. To identify the action of this network, we performed a genome-wide analysis of the regulatory actions of three key ventral determinants in mammalian neural tube patterning: Nkx2.2, Nkx6.1 and Olig2. Previous studies have demonstrated that each factor acts predominantly as a transcriptional repressor, at least in part, to inhibit alternative progenitor fate choices. Here, we reveal broad and direct repression of multiple alternative fates as a general mechanism of repressor action. Additionally, the repressor network targets multiple Shh signaling components providing negative feedback to ongoing Shh signaling. Analysis of chromatin organization around Nkx2.2-, Nkx6.1- and Olig2-bound regions, together with co-analysis of engagement of the transcriptional activator Sox2, indicate that repressors bind to, and probably modulate the action of, neural enhancers. Together, the data suggest a model for neural progenitor specification downstream of Shh signaling, in which Nkx2.2 and Olig2 direct repression of alternative neural progenitor fate determinants, an action augmented by the overlapping activity of Nkx6.1 in each cell type. Integration of repressor and activator inputs, notably activator inputs mediated by Sox2, is probably a key mechanism in achieving cell type-specific transcriptional outcomes in mammalian neural progenitor fate specification.

Indexed as

Models, BiologicalBasic Helix-Loop-Helix ProteinsChromatinChromatin ImmunoprecipitationGene Expression Regulation, DevelopmentalHedgehog ProteinsHomeobox Protein Nkx-2.2Homeodomain ProteinsHumansInterneuronsMotor NeuronsNerve Tissue ProteinsNeural Stem CellsNeural TubeNuclear ProteinsOligodendrocyte Transcription Factor 2Basic Helix-Loop-Helix ProteinsChromatinHedgehog ProteinsHomeobox Protein Nkx-2.2Homeodomain ProteinsNerve Tissue Proteinsnkx2.2b protein, zebrafishNKX2-2 protein, humanNkx2-2 protein, mouseNKX6-1 protein, humanNuclear ProteinsOLIG2 protein, humanOligodendrocyte Transcription Factor 2Repressor ProteinsSOX2 protein, humanSOXB1 Transcription FactorsTranscription FactorsZebrafish ProteinsFate specificationMouseNeural developmentTranscriptional regulation

Identifiers

PMID26293298
PMCPMC4631756
OpenAlexW2228067260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.